February 27, 2018 / 1:28 AM / 9 months ago

BRIEF-Akorn Says Does Not Believe Investigation Should Affect Closing Of Transaction With Fresenius​

Feb 26 (Reuters) - Akorn Inc:

* AKORN ISSUES STATEMENT ON INVESTIGATION

* AKORN - CO, ‍FRESENIUS, WITH ASSISTANCE OF CONSULTANTS, INVESTIGATING ALLEGED BREACHES OF FDA DATA INTEGRITY REQUIREMENTS RELATING TO PRODUCT DEVELOPMENT AT CO

* SAYS, ‍TO DATE, COMPANY’S INVESTIGATION HAS NOT FOUND ANY FACTS THAT WOULD RESULT IN A MATERIAL IMPACT ON AKORN’S OPERATIONS​

* ‍COMPANY DOES NOT BELIEVE THIS INVESTIGATION SHOULD AFFECT CLOSING OF TRANSACTION WITH FRESENIUS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below